Related Experiment Videos
Not norepinephrine but its oxidation products bind specifically to plasma proteins
F Boomsma1, A J Man in 't Veld, M A Schalekamp
1Department of Internal Medicine I, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
The Journal of Pharmacology and Experimental Therapeutics
|November 1, 1991
Summary
Specific binding of catecholamines to plasma proteins is often an artifact caused by oxidation products, not true binding. Ensuring ligand purity and stability is crucial for accurate results in binding assays.
Area of Science:
- Biochemistry
- Pharmacology
- Analytical Chemistry
Background:
- Conflicting reports exist regarding catecholamine binding to plasma proteins like albumin.
- Previous studies suggested significant specific binding of norepinephrine (NE) to human serum albumin.
Purpose of the Study:
- To investigate the artifactual binding of catecholamines to plasma proteins.
- To clarify the nature of norepinephrine (NE) binding to human serum albumin.
Main Methods:
- Binding studies using tritiated norepinephrine (NE) with human serum albumin.
- Investigating NE stability and oxidation products at varying pH and concentrations.
- Assessing binding in the presence of antioxidants and NE oxidation products.
Main Results:
- Specific binding of NE to albumin was identified as an artifact caused by oxidation products, particularly at pH > 6.5.
- The observed decrease in binding with increasing NE concentration was due to NE stability, not displacement.
- Real displacement was observed only with NE oxidation products, confirming their role in artifactual binding.
Conclusions:
- The specific binding of catecholamines to plasma proteins is largely an artifact of ligand oxidation.
- Ligand purity and stability are critical for accurate binding assay results, especially for catecholamines.
- Findings impact the interpretation of catecholamine release studies in various experimental settings.